Who has invested in Envisagenics?

Breakout Labs are named among the investors backing Envisagenics.

Envisagenics Funding: $2.3M Raised, Series B (2024)

Envisagenics funding overview

Envisagenics is based in New York. Envisagenics has raised $2.3M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in June 2024. The round record for Envisagenics runs through 2024; nothing later has been disclosed. Investors on record include Breakout Labs.

Envisagenics at a glance

Total raised: $2.3M
Latest round: Series B
Latest round date: June 2024
Headquarters: New York
Notable investors: Breakout Labs

Frequently asked about Envisagenics funding

How much has Envisagenics raised?: Envisagenics has raised $2.3M in total disclosed funding across the rounds on record.
Who has invested in Envisagenics?: Breakout Labs are named among the investors backing Envisagenics.
What was the latest Envisagenics funding round?: The most recent disclosed round is a Series B, announced in June 2024.
Where is Envisagenics based?: Envisagenics is based in New York.
When did Envisagenics last raise?: The last disclosed Envisagenics round closed in June 2024 at Series B.

Totals shown for Envisagenics aggregate every disclosed round on file. To see how that compares, browse the companies in New York and the investors behind them below.

Envisagenics Funding: $2.3M Raised, Series B (2024)

Envisagenics funding overview

Envisagenics at a glance

Frequently asked about Envisagenics funding

Companies related to Envisagenics (18)

Browse related funding lists (5)